CRISPR Therapeutics CRSP
$39.10 +$0.17 (+0.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.50 +1.02%
Open$38.18
Prev close$38.93
Day range$38.15 – $40.17
Volume3.32M
Market cap$3.79B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts12
Average target$74.27+89.9% vs. price
- Buy 67%
- Hold 33%
Low $50.00Now $39.10Avg $74.27High $110.00
Recent rating changes
The last 20 actions on file set price targets from $50.00 to $110.00, averaging $75.21.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | Needham | BUY | $82.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $80.00 |
| 9 Nov 2026 | UBS | HOLD | $52.00 |
| 9 Nov 2026 | Piper Sandler | BUY | $110.00 |
| 9 Nov 2026 | Needham | BUY | $82.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $80.00 |
| 9 Nov 2026 | J.P. Morgan | BUY | $67.00 |
| 8 Nov 2026 | Citi | BUY | $90.00 |
| 4 Nov 2026 | Wells Fargo | HOLD | $70.00 |
| 4 Nov 2026 | BofA Securities | BUY | $80.00 |
| 4 Nov 2026 | Citi | BUY | $90.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $80.00 |
| 3 Nov 2026 | Wells Fargo | HOLD | $70.00 |
| 3 Nov 2026 | UBS | HOLD | $52.00 |
| 3 Nov 2026 | Piper Sandler | BUY | $110.00 |
| 3 Nov 2026 | H.C. Wainwright | BUY | $80.00 |
| 3 Nov 2026 | RBC Capital | HOLD | $50.00 |
| 3 Nov 2026 | J.P. Morgan | BUY | – |
| 15 Oct 2026 | UBS | HOLD | $52.00 |
| 14 Oct 2026 | UBS | HOLD | $52.00 |
No comments yet — be the first to weigh in on CRSP.
Sign in to join the discussion.